Drug Company

Jul 26, 2016 at 15:08 | Source: PTI
The company had posted a profit of Rs 86.01 crore during the corresponding period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
Jul 26, 2016 at 13:46 | Source: PTI
The company has received approval from the United States Food and Drug Administration (USFDA) for generic "Bupivacaine hydrochloride in 8.25 per cent dextrose injection USP 7.5 mg/mL, single dose ampules with 2 ml fill volumes," Claris Lifesciences said in a BSE filing.
Jul 25, 2016 at 13:47 | Source:
Welcure Drugs & Pharmaceuticals Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on July 25, 2016.
Jul 25, 2016 at 09:20 | Source: PTI
The Rs 2,000-crore company launched sales through its online portal in 2008, which it subsequently rebranded to
Jul 23, 2016 at 13:12 | Source: PTI
The company had reported had posted a net profit of Rs 64.2 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
Jul 21, 2016 at 11:14 | Source: PTI
"Suven Life Sciences Ltd has undergone USFDA renewal inspection at their facility in Pashamylaram near Hyderabad for the manufacture and supply of active pharmaceutical ingredients (bulk drugs), intermediates and formulations under cGMP during April 4-14, 2016," the company said in a BSE filing.
Jul 20, 2016 at 11:30 | Source: PTI
"The company has received final approval by the US Food and Drug Administration (US FDA) for Rosuvastatin Calcium tablets," Aurobindo Pharma said in a BSE filing.
Jul 19, 2016 at 09:18 | Source: PTI
The company has launched the capsules in the strengths of 20mg/1100 mg and 40 mg/1100 mg after the approval from the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing to the BSE.
Jul 18, 2016 at 14:18 | Source: PTI
The company has launched the product in the US through its wholly-owned subsidiary, Ajanta Pharma USA Inc, Ajanta Pharma said in a filing to BSE.
Jul 18, 2016 at 11:22 | Source: PTI
"As per the agreement, SPARC will license Elepsia XRTM (Levetiracetam Extended Release tablets) to a wholly-owned subsidiary of Sun Pharma for the US market. SPARC will receive an up-front payment of USD 10 million from Sun Pharma," SPARC said in a BSE filing.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.